Bass Takes Aim At Citius Drug Patent Under His Own Name
Hedge fund manager Kyle Bass and self-described "patent troll" Erich Spangenberg challenged another drug patent Tuesday, this time taking aim at Citius Pharmaceuticals Inc.'s obesity drug Suprenza with an inter partes...To view the full article, register now.
Already a subscriber? Click here to view full article